47.69
price up icon1.21%   0.57
 
loading

Harrow Inc Aktie (HROW) Neueste Nachrichten

pulisher
06:27 AM

Can Harrow Inc. expand into new markets2025 Market Trends & Weekly Top Gainers Alerts - mfd.ru

06:27 AM
pulisher
02:00 AM

Precision Trading with Harrow Health Inc. 8.625% Senior Notes Due 2026 (HROWL) Risk Zones - Stock Traders Daily

02:00 AM
pulisher
Feb 12, 2026

Loss Report: What are the future prospects of Harrow IncQuarterly Growth Report & Fast Gain Stock Tips - baoquankhu1.vn

Feb 12, 2026
pulisher
Feb 11, 2026

Will Harrow Inc. stock attract more institutional investorsWeekly Trade Report & Weekly High Return Stock Forecasts - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Harrow, Inc. (HROW) Stock Analysis: A 48% Upside in the Promising Ophthalmic Pharmaceuticals Sector - DirectorsTalk Interviews

Feb 10, 2026
pulisher
Feb 07, 2026

Is Harrow’s (HROW) Reaffirmed 2025 Guidance Quietly Redefining Its Ophthalmic Growth Strategy? - simplywall.st

Feb 07, 2026
pulisher
Feb 06, 2026

Harrow Refocuses After ImprimisRx Exit As New CCO Takes Charge - Sahm

Feb 06, 2026
pulisher
Feb 05, 2026

A Look At Harrow’s (HROW) Valuation As 2025 Guidance Is Reaffirmed And Regulatory Issues Clear - Yahoo Finance

Feb 05, 2026
pulisher
Feb 04, 2026

New York State Common Retirement Fund Raises Stock Position in Harrow, Inc. $HROW - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

B.Riley reiterates Buy rating on Harrow Health stock amid VEVYE growth - Investing.com

Feb 04, 2026
pulisher
Feb 04, 2026

Harrow (NASDAQ:HROW) Downgraded by Zacks Research to "Hold" - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

Growth Recap: Should I hold or sell Harrow Inc now2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - baoquankhu1.vn

Feb 04, 2026
pulisher
Feb 03, 2026

Harrow Reaffirms FY2025 Revenue Growth Range Of 35% To 40%; Expands Sales Force - Nasdaq

Feb 03, 2026
pulisher
Feb 03, 2026

Harrow Stock (+9.7%): Commercial Expansion Ignites Institutional Buying - Trefis

Feb 03, 2026
pulisher
Feb 03, 2026

Strength Seen in Harrow (HROW): Can Its 9.7% Jump Turn into More Strength? - Nasdaq

Feb 03, 2026
pulisher
Feb 03, 2026

Rival quits California market; OSRX steps in to keep eye meds flowing - stocktitan.net

Feb 03, 2026
pulisher
Feb 03, 2026

How Harrow Health Inc. (HROW) Affects Rotational Strategy Timing - Stock Traders Daily

Feb 03, 2026
pulisher
Feb 02, 2026

Harrow on track to double sales force, expand product reach By Investing.com - Investing.com Nigeria

Feb 02, 2026
pulisher
Feb 02, 2026

OSRX Continues Support in California Market After Competitor Exit - Intellectia AI

Feb 02, 2026
pulisher
Feb 02, 2026

Harrow (NASDAQ:HROW) Shares Gap UpShould You Buy? - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Harrow on track to double sales force, expand product reach - Investing.com

Feb 02, 2026
pulisher
Feb 02, 2026

(HROW) Harrow Expects 2025 Revenue Range $270M$280M, vs. FactSet Est of $273.4M - marketscreener.com

Feb 02, 2026
pulisher
Feb 02, 2026

Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth - marketscreener.com

Feb 02, 2026
pulisher
Jan 29, 2026

Is Harrow Inc. attractive for institutional investors2025 Winners & Losers & Verified Momentum Stock Alerts - Mfd.ru

Jan 29, 2026
pulisher
Jan 29, 2026

Harrow Becomes Oversold (HROW) - Nasdaq

Jan 29, 2026
pulisher
Jan 29, 2026

Can Harrow Inc. be recession proofJuly 2025 Rallies & Daily Volume Surge Signals - mfd.ru

Jan 29, 2026
pulisher
Jan 26, 2026

Risk Report: Is PMTV stock showing strong momentum2025 Price Targets & Low Volatility Stock Recommendations - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 24, 2026

109,421 Shares in Harrow, Inc. $HROW Acquired by Blackhawk Capital Partners LLC - MarketBeat

Jan 24, 2026
pulisher
Jan 23, 2026

Harrow, Inc. (NASDAQ:HROW) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 23, 2026
pulisher
Jan 22, 2026

Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update (NASDAQ:HROW) - Seeking Alpha

Jan 22, 2026
pulisher
Jan 21, 2026

Harrow (NASDAQ:HROW) Shares Down 4.4%Time to Sell? - MarketBeat

Jan 21, 2026
pulisher
Jan 20, 2026

Market Trends: Can Harrow Inc expand into new marketsJuly 2025 Drop Watch & AI Enhanced Execution Alerts - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 20, 2026

Pharma News: Can Harrow Inc. be recession proofTrade Risk Assessment & Weekly High Return Stock Forecasts - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 20, 2026

Investment Recap: Can OptimizeRx Corporation weather a recessionQuarterly Trade Review & Weekly Setup with ROI Potential - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 19, 2026

Breakeven Is Near for Harrow, Inc. (NASDAQ:HROW) - Yahoo Finance

Jan 19, 2026
pulisher
Jan 19, 2026

Assessing Harrow (HROW) Valuation After Its Shift To An Integrated U.S. Eye Care Pharma Platform - Sahm

Jan 19, 2026
pulisher
Jan 18, 2026

LJI Wealth Management LLC Makes New Investment in Harrow, Inc. $HROW - MarketBeat

Jan 18, 2026
pulisher
Jan 18, 2026

Opaleye management sells $711,814 worth of Harrow shares - MSN

Jan 18, 2026
pulisher
Jan 18, 2026

Harrow announces leadership changes, Andrew Boll to serve as President and CFO - MSN

Jan 18, 2026
pulisher
Jan 16, 2026

Harrow, Inc. (NASDAQ:HROW) Could Be Less Than A Year Away From Profitability - 富途资讯

Jan 16, 2026
pulisher
Jan 15, 2026

Here's What Could Help Harrow (HROW) Maintain Its Recent Price Strength - sharewise.com

Jan 15, 2026
pulisher
Jan 15, 2026

Harrow, Inc. (HROW): A Bull Case Theory - Finviz

Jan 15, 2026
pulisher
Jan 14, 2026

Zacks Research Upgrades Harrow (NASDAQ:HROW) to "Strong-Buy" - MarketBeat

Jan 14, 2026
pulisher
Jan 13, 2026

Gap Down: Can Harrow Inc maintain sales growthBull Run & Safe Capital Allocation Plans - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 12, 2026

Harrow: Flirting With Missing 2025 Revised Guidance (NASDAQ:HROW) - Seeking Alpha

Jan 12, 2026
pulisher
Jan 12, 2026

Value Recap: Will Harrow Inc benefit from geopolitical trendsWeekly Trend Summary & Weekly Momentum Stock Picks - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 11, 2026

Responsive Playbooks and the HROW Inflection - Stock Traders Daily

Jan 11, 2026
drug_manufacturers_specialty_generic RDY
$14.14
price down icon 1.19%
$124.12
price up icon 0.83%
$25.13
price up icon 1.37%
drug_manufacturers_specialty_generic RGC
$31.22
price up icon 7.58%
$15.77
price down icon 0.13%
$473.66
price down icon 0.52%
Kapitalisierung:     |  Volumen (24h):